Acm Research (ACMR) | Financial Analysis & Statements
Acm Research Inc. Mid-cap Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
244.4M
Gross Profit
99.9M
40.87%
Operating Income
23.0M
9.42%
Net Income
14.2M
5.81%
Balance Sheet Metrics
Total Assets
2.9B
Total Liabilities
941.7M
Shareholders Equity
1.9B
Debt to Equity
0.49
Cash Flow Metrics
Operating Cash Flow
1.8M
Free Cash Flow
19.5M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Acm Research Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 901.3M | 782.1M | 557.7M | 388.8M | 259.8M |
| Cost of Goods Sold | 501.2M | 390.6M | 281.5M | 205.2M | 144.9M |
| Gross Profit | 400.1M | 391.6M | 276.2M | 183.6M | 114.9M |
| Gross Margin % | 44.4% | 50.1% | 49.5% | 47.2% | 44.2% |
| Operating Expenses | |||||
| Research & Development | 145.0M | 105.5M | 92.7M | 62.2M | 34.2M |
| Selling, General & Administrative | 145.6M | 135.1M | 87.7M | 62.4M | 41.9M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 290.6M | 240.6M | 180.4M | 124.6M | 76.2M |
| Operating Income | 109.4M | 151.0M | 95.8M | 59.0M | 38.7M |
| Operating Margin % | 12.1% | 19.3% | 17.2% | 15.2% | 14.9% |
| Non-Operating Items | |||||
| Interest Income | 14.6M | 9.9M | 8.4M | 8.7M | 505.0K |
| Interest Expense | 7.0M | 4.2M | 2.7M | 1.7M | 765.0K |
| Other Non-Operating Income | 18.1M | 9.5M | 14.7M | 1.2M | 4.6M |
| Pre-tax Income | 135.2M | 166.3M | 116.2M | 67.4M | 43.1M |
| Income Tax | 13.3M | 35.0M | 19.4M | 16.8M | 134.0K |
| Effective Tax Rate % | 9.8% | 21.1% | 16.7% | 24.9% | 0.3% |
| Net Income | 121.9M | 131.3M | 96.9M | 50.6M | 42.9M |
| Net Margin % | 13.5% | 16.8% | 17.4% | 13.0% | 16.5% |
| Key Metrics | |||||
| EBITDA | 140.9M | 177.7M | 120.7M | 81.1M | 45.6M |
| EPS (Basic) | $1.47 | $1.67 | $1.29 | $0.66 | $0.65 |
| EPS (Diluted) | $1.37 | $1.53 | $1.16 | $0.59 | $0.58 |
| Basic Shares Outstanding | 64184776 | 62212569 | 60164670 | 59235975 | 57654708 |
| Diluted Shares Outstanding | 64184776 | 62212569 | 60164670 | 59235975 | 57654708 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Acm Research Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 757.4M | 407.4M | 182.1M | 248.0M | 562.5M |
| Short-term Investments | 402.1M | 36.6M | 101.8M | 90.7M | 29.5M |
| Accounts Receivable | 504.2M | 387.0M | 283.2M | 182.9M | 105.6M |
| Inventory | 702.6M | 598.0M | 545.4M | 393.2M | 218.1M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 2.4B | 1.5B | 1.2B | 963.8M | 952.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 88.6M | 51.1M | 23.6M | 11.8M | 12.2M |
| Goodwill | 2.8M | 3.5M | 10.9M | 9.9M | 10.9M |
| Intangible Assets | 2.8M | 3.5M | 10.9M | 9.9M | 10.9M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 33.9M | 16.8M | 21.4M | 7.9M | 14.4M |
| Total Non-Current Assets | 435.5M | 372.3M | 314.8M | 271.7M | 99.2M |
| Total Assets | 2.9B | 1.9B | 1.5B | 1.2B | 1.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 215.4M | 139.3M | 141.8M | 101.7M | 93.5M |
| Short-term Debt | 113.9M | 79.4M | 40.9M | 59.7M | 14.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 745.7M | 641.2M | 500.7M | 396.2M | 205.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 184.0M | 109.4M | 58.2M | 19.8M | 24.8M |
| Deferred Tax Liabilities | - | - | - | 0 | 1.3M |
| Other Non-Current Liabilities | 12.0M | 1.2M | 1.3M | 1.7M | 684.0K |
| Total Non-Current Liabilities | 196.0M | 118.6M | 64.1M | 27.1M | 34.6M |
| Total Liabilities | 941.7M | 759.8M | 564.7M | 423.3M | 240.5M |
| Equity | |||||
| Common Stock | 7.0K | 7.0K | 7.0K | 6.0K | 6.0K |
| Retained Earnings | 350.4M | 260.0M | 156.8M | 94.4M | 63.7M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.9B | 1.1B | 926.2M | 812.2M | 811.7M |
| Key Metrics | |||||
| Total Debt | 297.9M | 188.8M | 99.1M | 79.5M | 39.1M |
| Working Capital | 1.7B | 842.1M | 675.5M | 567.6M | 747.0M |
Balance Sheet Composition
Acm Research Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 121.9M | 131.3M | 96.9M | 50.6M | 42.9M |
| Depreciation & Amortization | 16.3M | 10.0M | 8.1M | 5.4M | 2.4M |
| Stock-Based Compensation | 33.6M | 49.6M | 27.3M | 7.7M | 5.1M |
| Working Capital Changes | -197.1M | -113.3M | -210.3M | -163.4M | -91.3M |
| Operating Cash Flow | -35.1M | 86.6M | -88.0M | -92.9M | -40.2M |
| Investing Activities | |||||
| Capital Expenditures | -55.6M | -82.5M | -61.9M | -91.1M | -9.2M |
| Acquisitions | - | - | - | -1.0M | -1.6M |
| Investment Purchases | -389.8M | -101.0M | -52.0M | -177.7M | -1.6M |
| Investment Sales | 56.4M | 175.0M | 109.6M | 4.6M | 0 |
| Investing Cash Flow | -389.0M | -8.5M | -4.3M | -437.7M | -12.3M |
| Financing Activities | |||||
| Share Repurchases | -7.0M | - | - | - | 0 |
| Dividends Paid | -7.6M | -6.9M | -4.0M | 0 | 0 |
| Debt Issuance | 119.1M | 96.9M | 42.4M | 0 | 7.1M |
| Debt Repayment | -107.6M | -41.9M | -57.4M | -11.4M | -41.9M |
| Financing Cash Flow | 660.4M | 49.1M | -42.7M | 35.3M | 493.7M |
| Free Cash Flow | -68.0M | 66.5M | -139.7M | -154.7M | -49.8M |
| Net Change in Cash | 236.3M | 127.2M | -135.0M | -495.3M | 441.2M |
Cash Flow Trend
Acm Research Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
41.60
Forward P/E
24.99
Price to Book
2.55
Price to Sales
4.16
PEG Ratio
-0.55
Profitability Ratios
Profit Margin
10.44%
Operating Margin
9.42%
Return on Equity
8.06%
Return on Assets
2.89%
Financial Health
Current Ratio
3.27
Debt to Equity
15.43
Beta
1.68
Per Share Data
EPS (TTM)
$1.37
Book Value per Share
$22.32
Revenue per Share
$14.04
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ACMR | 3.7B | 41.60 | 2.55 | 8.06% | 10.44% | 15.43 |
| Lam Research | 324.8B | 54.64 | 32.75 | 65.57% | 30.22% | 44.20 |
| Applied Materials | 331.0B | 42.91 | 15.26 | 38.86% | 27.78% | 33.11 |
| Camtek | 9.4B | 188.36 | 14.55 | 8.70% | 10.23% | 86.03 |
| Ipg Photonics | 5.2B | 169.26 | 2.45 | 1.50% | 3.10% | 0.81 |
| Kulicke & Soffa | 4.4B | 5,567.00 | 5.40 | -7.19% | -9.40% | 4.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.






